Enterprise Value
0.00
Cash
123.6M
Avg Qtr Burn
N/A
Short % of Float
1.10%
Insider Ownership
3.47%
Institutional Own.
87.64%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
IVX-A12 (RSV+hMPV) Details Respiratory syncytial virus, Vaccine, Human metapneumovirus | Phase 2 Update | |
IVX-121 Details Respiratory syncytial virus | Phase 1/2 Update | |
IVX-411 Details COVID-19 | Failed Discontinued |